Wednesday, 23 Sep 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
MediTrust Mabwell Insurance Ecosystem Partnership
CompanyDeals

MediTrust Mabwell Insurance Ecosystem Partnership

February 5, 2026
CompanyDrug

Hanx Biopharma HX111 ADC Begins Phase I Trial for Lymphoma and Solid Tumors

February 5, 2026
Pfizer Launches Migraine Management Zone at China Pharmacy
CompanyDeals

Pfizer Launches Migraine Management Zone at China Pharmacy

February 5, 2026
CompanyDrug

Shouyao’s SY-9453 MAT2A Inhibitor Gets NMPA Nod for MTAP-Deleted Tumors

February 5, 2026
Innovent Biologics Revenue Surges 45% on Oncology Portfolio Expansion
Company

Innovent Biologics Revenue Surges 45% on Oncology Portfolio Expansion

February 5, 2026
CompanyDrug

Huadong Medicine DR10624 Gets NMPA Nod for Hypertriglyceridemia Study

February 5, 2026
CompanyDeals

Takeda Ends $128M Kyoto University iPSC Project After Decade of Research

May 14, 2026
HospitalPolicy / Regulatory

Beijing Online Consultation Pilot Gets NHC Approval for Children’s Care

February 5, 2026
AstraZeneca Saphnelo Faces FDA Setback with Complete Response Letter
CompanyDrug

AstraZeneca Saphnelo Faces FDA Setback with Complete Response Letter

February 5, 2026
AbbVie Immunology Portfolio Drives $61.2B Revenue in 2025
Company

AbbVie Immunology Portfolio Drives $61.2B Revenue in 2025

February 5, 2026
CompanyDeals

Mirxes Partners with XtalPi and Signet on AI-Driven Gastric Cancer System

February 5, 2026
Lishan Biopharma Licenses Evogene’s LS-LBP-002 for Global Oncology Development
CompanyDeals

Lishan Biopharma Licenses Evogene’s LS-LBP-002 for Global Oncology Development

February 5, 2026
1 2 … 12 13 14 15 16 … 18 19
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up